Novo Nordisk A/S

These stocks are trying to solve a major shortcoming of weight loss drugs: Shrinking muscle mass
Health

These stocks are trying to solve a major shortcoming of weight loss drugs: Shrinking muscle mass

One of the downsides of taking new anti-obesity medications is that patients tend to lose lean muscle mass along with body fat. What this means for patients over the long term isn’t fully known, but there are several pharmaceutical companies studying the side effect and hoping to develop therapies that might regulate the condition. In […]

Read More
Sanofi to offer insulin product for  to all Americans through GoodRx
Health

Sanofi to offer insulin product for $35 to all Americans through GoodRx

Sanofi Lantus brand insulin pens are arranged for a photograph in the Brooklyn borough of New York, U.S., on Friday, April 5, 2019. Alex Flynn | Bloomberg | Getty Images Americans, regardless of their insurance status, can now access Sanofi‘s most widely prescribed insulin for $35 through the prescription drug savings company GoodRx, the companies […]

Read More
GLP-1 pounds reduction medicine are making prospects for these 2 stocks, investment advisor claims
World

GLP-1 pounds reduction medicine are making prospects for these 2 stocks, investment advisor claims

GP1-1 (glucagon-like peptide-1) medicines, initially made as a therapy for diabetic issues, are shaking up some sectors. Developments encompassing the prescription drugs, also commonly made use of for fat decline, have been disrupting anything at all from owners of dialysis facilities to bariatric medical procedures providers and the foodstuff marketplace. But just one financial investment […]

Read More
CNBC Professional Talks: Munro Partners’ Nick Griffin to examine AI, Significant Tech and stocks to short
World

CNBC Professional Talks: Munro Partners’ Nick Griffin to examine AI, Significant Tech and stocks to short

Artificial intelligence shares have been on a tear this 12 months, but is it too late to spend? Sign up for CNBC’s Will Koulouris as he quizzes Nick Griffin, chief investment decision officer of Munro Associates, on the AI concept, Big Tech, and how to enjoy shares this sort of as Nvidia and Microsoft . Submit […]

Read More
‘Miracle drug’ euphoria: Specialists warn widespread use of fat decline medicine faces main hurdles
World

‘Miracle drug’ euphoria: Specialists warn widespread use of fat decline medicine faces main hurdles

Two gurus see key difficulties facing the adoption of new being overweight medicine. Dr. Kavita Patel, a physician and NBC News health-related contributor, thinks new knowledge from Novo Nordisk on Ozempic’s means to hold off the development of long-term kidney disease is among the strongest supporting proof for secondary uses of the drug. On the […]

Read More
Many are betting Ozempic will reduce the need for knee surgery. What it means if they’re wrong
Health

Many are betting Ozempic will reduce the need for knee surgery. What it means if they’re wrong

Medical device stocks of all kinds were pummeled over the past week as investors tried to calculate the ripple effects of new weight loss drugs. It wasn’t the first rout in the sector — the pressure has persisted for several months. The fear has been that whenever you have a large group of consumers changing […]

Read More
Novo Nordisk hikes outlook on soaring demand for Wegovy, Ozempic
Business

Novo Nordisk hikes outlook on soaring demand for Wegovy, Ozempic

An Ozempic (semaglutide) injection pen is seen on a kitchen table in Riga, Latvia on 06 August, 2023.  Jaap Arriens | Nurphoto | Getty Images Novo Nordisk on Friday raised its outlook for its full-year sales and operating profit due to soaring demand for its blockbuster weight loss drug Wegovy and diabetes treatment Ozempic.  The […]

Read More
LVMH shares tumble to 2023 small as growth slows, pulling luxury sector down
World

LVMH shares tumble to 2023 small as growth slows, pulling luxury sector down

A LVMH Moet Hennessy Louis Vuitton SE store in Shanghai, China on Wednesday, June 14, 2023. Bloomberg | Bloomberg | Getty Illustrations or photos Shares of LVMH dropped to their least expensive amount of the yr on Wednesday morning, just after the corporation reported a slowdown in income progress that was beneath anticipations. The stock […]

Read More
How Ozempic and Wegovy turned Novo Nordisk into a 0 billion company
Health

How Ozempic and Wegovy turned Novo Nordisk into a $400 billion company

Danish drugmaker Novo Nordisk has entered a new chapter in its 100-year history — thanks to its newfound success with two products: Ozempic and Wegovy.  The drugs are once-weekly injectables of a medication called semaglutide, prescribed for Type 2 diabetes and weight loss. Their skyrocketing popularity has boosted Novo Nordisk to new heights. Novo Nordisk’s […]

Read More
Weight loss drugs may be linked to stomach paralysis, other rare but severe issues, study says
Health

Weight loss drugs may be linked to stomach paralysis, other rare but severe issues, study says

Still life of Wegovy an injectable prescription weight loss medicine that has helped people with obesity. It should be used with a weight loss plan and physical activity.  Michael Siluk | UCG | Getty Images Blockbuster weight loss and diabetes drugs like Wegovy and Ozempic may be associated with an increased risk of three rare, […]

Read More